MX2018002786A - Composicion farmaceutica de vinpocetina. - Google Patents

Composicion farmaceutica de vinpocetina.

Info

Publication number
MX2018002786A
MX2018002786A MX2018002786A MX2018002786A MX2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A
Authority
MX
Mexico
Prior art keywords
vinpocetine
pharmaceutical composition
epilepsy
treatment
present
Prior art date
Application number
MX2018002786A
Other languages
English (en)
Inventor
Angel ESPINOSA ALFARO Miguel
Sitges Berrondo Maria
Original Assignee
Neolpharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neolpharma Inc filed Critical Neolpharma Inc
Publication of MX2018002786A publication Critical patent/MX2018002786A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

La presente invención está dirigida a una composición farmacéutica de liberación prolongada que comprende vinpocetina como principio activo. También se describe la farmacocinética de la composición farmacéutica. La composición divulgada se encuentra dirigida al tratamiento de enfermedades del sistema nervioso central como lo son la epilepsia y epilepsia refractaria.
MX2018002786A 2015-09-03 2015-09-03 Composicion farmaceutica de vinpocetina. MX2018002786A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2015/048295 WO2017039670A1 (en) 2015-09-03 2015-09-03 Vinpocetine pharmaceutical composition

Publications (1)

Publication Number Publication Date
MX2018002786A true MX2018002786A (es) 2018-12-17

Family

ID=58188718

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002786A MX2018002786A (es) 2015-09-03 2015-09-03 Composicion farmaceutica de vinpocetina.

Country Status (2)

Country Link
MX (1) MX2018002786A (es)
WO (1) WO2017039670A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
CN100500146C (zh) * 2003-10-28 2009-06-17 墨西哥国立自治大学 长春西汀及其衍生物在癫痫及其并发症的治疗和预防中的应用
US20050096369A1 (en) * 2003-11-04 2005-05-05 Hoang Ba X. Compositions and methods for treating cellular proliferation disorders
WO2010002835A2 (en) * 2008-07-03 2010-01-07 Osteogenex, Inc. Vinpocetine and eburnamonine derivatives for promoting bone growth

Also Published As

Publication number Publication date
WO2017039670A1 (en) 2017-03-09

Similar Documents

Publication Publication Date Title
PH12018500586A1 (en) Farnesoid x receptor agonists and uses thereof
MX2021000071A (es) Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer.
NZ735000A (en) Methods for the treatment of abnormal involuntary movement disorders
PH12017500401A1 (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
MX2017006437A (es) Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor.
MX2021010041A (es) Composiciones farmaceuticas que comprenden inhibidores de la proteina quinasa akt.
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP3336100A4 (en) PEPTIDE WITH EFFECT FOR PREVENTING OR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM THEREFOR AS AN ACTIVE SUBSTANCE
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12018500814A1 (en) Oxadiazaspiro compounds for the treatment of drug abuse and addiction
MD4763B1 (ro) Compoziţie farmaceutică
PH12018500682A1 (en) Oxa-diazaspiro compounds having activity against pain
MX2018002786A (es) Composicion farmaceutica de vinpocetina.
MX2019004736A (es) Mini-tabletas de melatonina y metodos de fabricacion de las mismas.
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
MX2018004774A (es) Derivados de morfolina sustituidos que tienen actividad contra el dolor.
MX2018003564A (es) 1,4-benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cancer.
MX2018004776A (es) Compuestos oxaazaespiricos con actividad contral el dolor.
MX2018000418A (es) Derivados de amida que tienen actividad multimodal contra el dolor.
MX2019014773A (es) Inhibidores de ccl2.
EA201692221A1 (ru) Фармацевтическая композиция для профилактики и лечения заболеваний, связанных с повышенной активностью индуцируемой синтазы окиси азота
MX2014013240A (es) Composicion farmaceutica para el tratamiento de la disfuncion erectil a base de un farmaco inhibidor de la enzima pde-5 (fosfodiesterasa tipo 5) en tabletas.